KEQU News & Events

Reports Q1 revenue $71.1M vs. $48.3M last year. "Our Domestic and International segments delivered solid financial performance in Q1 despite challenging market conditions as a result of uncertain government policy, evolving tariff structures and broader geopolitical upheaval," said CEO Thomas Hull III. "While our overall backlog remains near historically high levels, we are experiencing volatility in project delivery timelines that we expect will cause uneven performance by quarter for the balance of fiscal year 2026, likely starting in the second quarter. This is a reality of both the uncertainty in the market, and the nature of construction-related manufacturing, where project timing often shifts, causing peaks and valleys in production schedules. Kewaunee is focused on growth, both organically and inorganically, and is committed to making strategic investments in the people, processes, and technology that will support and enable this growth in a sustainable manner. These important investments are accounted for in the Corporate segment and, while some of the costs are expected to be non-recurring in nature, many of them will not be. Though this will place pressure on earnings growth in the near term, we believe it will position Kewaunee for rapid and sustained growth in the future, allowing us to gain leverage on these investments over the long term."

Reports Q1 revenue $71.1M vs. $48.3M last year. "Our Domestic and International segments delivered solid financial performance in Q1 despite challenging market conditions as a result of uncertain government policy, evolving tariff structures and broader geopolitical upheaval," said CEO Thomas Hull III. "While our overall backlog remains near historically high levels, we are experiencing volatility in project delivery timelines that we expect will cause uneven performance by quarter for the balance of fiscal year 2026, likely starting in the second quarter. This is a reality of both the uncertainty in the market, and the nature of construction-related manufacturing, where project timing often shifts, causing peaks and valleys in production schedules. Kewaunee is focused on growth, both organically and inorganically, and is committed to making strategic investments in the people, processes, and technology that will support and enable this growth in a sustainable manner. These important investments are accounted for in the Corporate segment and, while some of the costs are expected to be non-recurring in nature, many of them will not be. Though this will place pressure on earnings growth in the near term, we believe it will position Kewaunee for rapid and sustained growth in the future, allowing us to gain leverage on these investments over the long term."

Kewaunee Scientific announced an amendment to its existing share repurchase program. The Board of Directors of Kewaunee Scientific amended its existing share repurchase program initially approved on August 31, 2023, and in effect September 1, 2023. The Board of Directors authorized the repurchase of up to an additional 100,000 shares of the company's common stock under the existing share repurchase program, which does not have a specified expiration date. The Program, as of the end of day March 12, 2025 and prior to this amendment, still had 11,176 shares authorized for repurchase which remain authorized for repurchase and are unaffected by this amendment.

Reports Q3 revenue $47.75M vs. $50.44M last year. "Our financial performance for the second quarter of fiscal year 2025 was strong," said CEO Thomas Hull III. "Domestic segment operating performance improved compared to last year's second quarter as a result of higher product demand, highlighting our continued health and advantage in the market. As discussed during Q1 FY25, customer construction site delays in India on multiple projects continue to impact our ability to ship products and deliver services, leading to a decrease in sales and earnings when compared to the prior year Q2. Looking ahead, our backlog remains very healthy, demonstrating the continued vitality and investment in the markets in which Kewaunee participates and the success both Kewaunee and our channel partners continue to achieve in the marketplace. The strength of Kewaunee's backlog positions the company well to deliver another strong year for our fiscal year. Additionally, on November 1, 2024, Kewaunee announced the acquisition of Nu Aire. Nu Aire is renowned for its manufacturing of robust containment solutions, such as biological safety cabinets, airflow products, and more, which serve a diverse range of industries. While not reflected in our Q2 FY25 results, Nu Aire will be included going forward, beginning with our Q3 FY25 results. It is worth noting the company incurred expenses related to the acquisition of $2.3M in the current fiscal year."